Diversity, Goals of Graduating Medical Students Pursuing Careers in Dermatology

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.4984?guestAccessKey=da7b5ee2-ab74-42e6-b6c5-662a94e01281&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111622

Diversity Trends Among Dermatology Resident Trainees Compared With Other Specialties

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time

https://jamanetwork.com/journals/jamadermatology/fullarticle/10.1001/jamadermatol.2022.4991?guestAccessKey=868fdf0e-630d-44d1-a885-0cd197948c5c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111622

Association Between Loneliness, Postoperative Mortality Among Medicare Patients

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 16, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.4784?guestAccessKey=db6a90be-b152-49b0-a320-0c948fc25a98&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111622

 

About The Study: In this study of 4,400 Medicare patients, self-reported loneliness was associated with an increased risk of death at 30 days after non-elective surgery. The findings suggest that loneliness may be an important social determinant of postoperative outcomes, particularly for non-elective care.

Authors: Jennifer F. Waljee, M.D., M.P.H., of the Center for Healthcare Outcomes and Policy in Ann Arbor, Michigan, is the corresponding author.

 

(doi:10.1001/jamasurg.2022.4784)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

COVID-19 Vaccination Status Among Parents of Hospitalized Children With SARS-CoV-2 Infection

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 16, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.42295?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111622

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers found in this study that parental vaccination was associated with a reduced risk of COVID-19 hospitalization in children younger than age 5 during the Delta and Omicron waves. These results reinforce recommendations for widespread vaccination of parents of young children.

Authors: François Angoulvant, M.D., Ph.D., of Lausanne University Hospital in Lausanne, Switzerland, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.42295

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Maternal Preeclampsia With Offspring Risks of Ischemic Heart Disease, Stroke

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 15, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.42064?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111522

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Results of this study involving almost 8.5 million participants in Nordic countries suggest that offspring born to individuals with preeclampsia had increased ischemic heart disease and stroke risk that were not fully explained by preterm or small for gestational age birth, and that the associated risks for stroke were higher for severe forms of preeclampsia. 

Authors: Fen Yang, M.D., M.Sc., of the Karolinska Institutet in Stockholm, and Imre Janszky, M.D., Ph.D., of the Norwegian University of Science and Technology in Trondheim, Norway, are the corresponding authors. 

 

(doi:10.1001/jamanetworkopen.2022.42064)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Post–COVID-19 Symptoms 2 Years After SARS-CoV-2 Infection Among Hospitalized vs Non-hospitalized Patients

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 15, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.42106?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111522

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This cross-sectional study suggested the presence of at least one post–COVID-19 symptom in 59.7% of hospitalized patients and 67.5% of non-hospitalized patients two years after infection. Small differences in symptoms at onset of COVID-19 were identified between hospitalized and non-hospitalized patients. Post–COVID-19 symptoms were similar between hospitalized and non-hospitalized patients; however, lack of inclusion of uninfected controls limits the ability to assess the association of SARS-CoV-2 infection with overall and specific post–COVID-19 symptoms two years after acute infection. Future studies should include uninfected control populations. 

Authors: Cesar Fernandez-de-las-Penas, P.T., Ph.D., of the Universidad Rey Juan Carlos in Madrid, is the corresponding author. 

 

(doi:10.1001/jamanetworkopen.2022.42106)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Physical Activity With Neurofilament Light Chain Trajectories in Autosomal Dominant Frontotemporal Lobar Degeneration Variant Carriers

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.4178?guestAccessKey=a1229f6f-b961-4153-bd6a-cd8eaab9a651&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111422

Associations Between State-Level Changes in Reproductive Health Services, Indicators of Severe Maternal Morbidity

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.4136?guestAccessKey=4e7421bd-d68c-463b-a236-505616d6e8b2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111422

Brain Aging Among Racially, Ethnically Diverse Middle-Age, Older Adults

JAMA Neurology

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 14, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.3919?guestAccessKey=4837beb7-8733-44ce-8320-8264f103b0e6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111422

 

About The Study: In this study of two community-based cohort studies in midlife (n = 497) and late life (n = 970), racial and ethnic disparities in small vessel cerebrovascular disease were apparent in midlife. In Latinx and white adults, brain aging was more pronounced in late life than midlife, whereas Black adults showed an accelerated pattern of brain aging beginning in midlife. Race and ethnicity disparities in aging and Alzheimer disease and related dementias may be due partially to social forces that accelerate brain aging, especially in Black middle-age adults.

Authors: Adam M. Brickman, Ph.D., of Columbia University in New York, is the corresponding authors.

 

(doi:10.1001/jamaneurol.2022.3919)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

USPSTF Recommendation Statement on Screening for Obstructive Sleep Apnea in Adults

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 15, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20304?guestAccessKey=d0ba33ac-596a-46dd-9d58-c5ab6e0fa679&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111522

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to make a recommendation about screening for obstructive sleep apnea (OSA) in the general adult population. This statement applies to asymptomatic adults and adults with unrecognized symptoms of OSA. Current prevalence of OSA in the United States is not well established. In 2007-2010 the estimated prevalence of at least mild OSA plus symptoms of daytime sleepiness among adults ages 30 to 70 was 14% for men and 5% for women, and the estimated prevalence of moderate to severe OSA was 13% for men and 6% for women. Adverse health outcomes associated with untreated OSA include cardiovascular disease and cerebrovascular events, type 2 diabetes, cognitive impairment, decreased quality of life, and motor vehicle crashes. Severe OSA is associated with increased all-cause mortality. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this statement is consistent with its 2017 recommendation on screening for OSA.

(doi:10.1001/jama.2022.20304)

 

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

Visual Abstract: Effect of Extending the Duration of Pre-quit Treatment With Varenicline on Smoking Abstinence

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 11, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.41731?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111122

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Larry W. Hawk Jr., Ph.D., of the University at Buffalo in Buffalo, New York, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.41731)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Comparison of Acupuncture vs Sham Acupuncture in Treatment of Aromatase Inhibitor–Related Joint Pain

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 11, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.41720?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111122

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Dawn L. Hershman, M.D., M.S., of the Columbia University Irving Medical Center in New York, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.41720)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Electronic Health Record Legal Settlements Since 2009 Health Information Technology for Economic and Clinical Health Act

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3872?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111122

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Financial Outcomes After Traumatic Injury Among Working-Age Adults With Commercial Insurance

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.4105?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111122

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Early Adoption of Anti–SARS-CoV-2 Pharmacotherapies Among Veterans With Mild to Moderate COVID-19

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 11, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.41434?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111122

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this study of more than 111,000 veterans who tested positive for SARS-CoV-2 during January and February 2022 when supply of outpatient COVID-19 pharmacotherapies was limited, prescription of these pharmacotherapies was underused, and many veterans with risk factors for severe COVID-19 did not receive treatment. Veterans from minority racial and ethnic groups were less likely to receive any pharmacotherapy. 

Authors: Kristina L. Bajema, M.D., M.Sc., of the Veterans Affairs Portland Health Care System in Portland, Oregon, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.41434)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Food Insufficiency Following Discontinuation of Child Tax Credit Among Lower-Income Households

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 11, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.4039?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111122

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: Discontinuation of monthly Child Tax Credit payments in December 2021 was associated with a significant increase in household food insufficiency among lower-income households, with the greatest increase occurring in the lowest-income households, according to survey data from the U.S. Census Bureau.

Authors: Zoe Bouchelle, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.4039)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association Between Social Disparities, Ear Infection Treatment in Children

JAMA Otolaryngology–Head & Neck Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 10, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2022.3560?guestAccessKey=0dc78476-a0a3-424f-9837-ed5a5a74f0de&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111022

 

About The Study: The findings of this study of 4.8 million children with otitis media (infection of the middle ear) and commercial insurance suggest that those who were socially disadvantaged were less likely to receive treatment and more likely to experience complications for undertreated otitis media. As otitis media is a modifiable risk factor for hearing loss, efforts need to be made to ensure equitable access to treatment for all children. 

Authors: Z. Jason Qian, M.D., of the Stanford University School of Medicine in Stanford, California, is the corresponding author.

 

(doi:10.1001/jamaoto.2022.3560)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Perspectives of Emergency Clinicians About Medical Errors Resulting in Patient Harm or Malpractice Litigation

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 10, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.41461?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=111022

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This cross-sectional study investigated emergency department clinicians’ concerns about medical errors resulting in either patient harm or malpractice litigation. 

Authors: Linda M. Isbell, Ph.D., of the University of Massachusetts Amherst, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.41461)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Preexisting Neuropsychiatric Conditions, Associated Risk of Severe COVID-19 Infection, Other Acute Respiratory Infections

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.3614?guestAccessKey=0f7a5fbc-74fb-4ebd-ad5c-072e20611fec&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110922

Results of a Remotely Delivered Hypertension, Lipid Program Across a Diverse Health Care Network

JAMA Cardiology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 9, 2022

Media advisory: The full study and commentary are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamacardiology/fullarticle/10.1001/jamacardio.2022.4018?guestAccessKey=0ca9cc74-23c4-44db-b1d5-38e3583d5461&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110922

 

About The Study: The results of this study that included more than 10,000 patients with blood pressure and/or cholesterol levels above guideline-recommended targets indicate that a standardized remote blood pressure and cholesterol management program may help optimize guideline-directed therapy at scale, reduce cardiovascular risk, and minimize the need for in-person visits among diverse populations. 

Authors: Benjamin M. Scirica, M.D., M.P.H., of Brigham and Women’s Hospital in Boston, is the corresponding author.

 

(doi:10.1001/jamacardio.2022.4018)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Racial, Ethnic Disparities in Buprenorphine Treatment Duration

JAMA Psychiatry

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 9, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapsychiatry/fullarticle/10.1001/jamapsychiatry.2022.3673?guestAccessKey=98ccf8b9-2207-4814-9bce-9b62cb92b500&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110922

  

About The Study: This analysis found that racial and ethnic disparities in buprenorphine treatment duration increased between 2006 and 2020, particularly during more recent years. Buprenorphine is used to treat opioid use disorder and reduce overdose risk. Duration of buprenorphine treatment is a measure of quality of care; longer retention is associated with superior clinical outcomes.

Authors: Mohammad S. Jalali, Ph.D., of Harvard Medical School in Boston, is the corresponding author.

 

(10.1001/jamapsychiatry.2022.3673)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Treatment Time, In-Hospital Mortality Among Patients With ST-Segment Elevation Heart Attack, 2018-2021

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20149?guestAccessKey=82549a0b-7383-4bb2-9cef-8b9e583ce317&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110622

Association of State-Level Firearm Deaths With Firearm Laws in Neighboring States

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40750?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this pooled analysis involving firearm laws and firearm-related deaths from 2000 to 2019 in the 48 contiguous states, a permit requirement for purchasing all firearms had an interstate association with decreased total firearm-related deaths and homicide, whereas the prohibition of firearm possession for individuals who have committed a violent misdemeanor had an interstate association with decreased firearm suicide. These findings suggest that synergic legislative action to implement firearm laws in proximate states may help prevent firearm-related deaths.

Authors: Ye Liu, M.D., M.P.H., of the University of Alabama at Birmingham, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.40750)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Analysis of Electrolyte Abnormalities in Adolescents, Adults and Subsequent Diagnosis of an Eating Disorder

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 8, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40809?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this case-control study of individuals age 13 or older without a prior eating disorder diagnosis, researchers found that an outpatient electrolyte abnormality was associated with an over 2-fold higher odds of a subsequent eating disorder diagnosis. The median time from the earliest electrolyte abnormality to eating disorder diagnosis exceeded one year. These results suggest that otherwise unexplained outpatient electrolyte abnormalities may serve to identify individuals who should be screened for an underlying eating disorder.

Authors: Gregory L. Hundemer, M.D., M.P.H., of the University of Ottawa in Ottawa, Canada, is the corresponding author.

 

 (doi:10.1001/jamanetworkopen.2022.40809)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Changes in Distribution of Severe Neurologic Involvement in Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.3881?guestAccessKey=a4dd6f39-caa0-4dac-9ba3-09abecc04b7f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110722

Daily Low-Dose Aspirin, Risk of Serious Falls, Fractures in Healthy Older Adults

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.5028?guestAccessKey=9e5db703-5cd3-45d9-8344-72e06f6828cf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110722

Rate of Recurrence After Discontinuing Anticoagulation Therapy in Patients With COVID-19–Associated Venous Thromboembolism

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.4954?guestAccessKey=21732c6d-0a55-4bda-8218-0edf6905224d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110722

Trends in Urinary Biomarkers of Exposure to Nicotine, Carcinogens Among e-Cigarette Vapers vs Cigarette Smokers

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14847?guestAccessKey=311b458a-1494-4fa7-bf1f-fbbb421a04a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110822

Changes in Child, Adolescent Screen Time During Pandemic

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 7, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.4116?guestAccessKey=2bb83659-b469-4a2f-b60e-9480451e3616&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110722

 

About The Study: This systematic review and meta-analysis of 46 studies including 29,000 children and adolescents indicates that, on average, screen time increased by 52%, or 84 min/day (1.4 hours/day), during the pandemic. Compared with a pre-pandemic baseline value of 2.7 hours/day, this increase corresponds to a daily average of 4.1 hours/day of screen time across all children and adolescents during the pandemic. Screen time increases were highest for individuals ages 12 to 18 and for handheld devices and personal computers. Practitioners and pandemic recovery initiatives should focus on fostering healthy device habits, including moderating use, monitoring content, prioritizing device-free time, and using screens for creativity or connection.

Authors: Sheri Madigan, Ph.D., of the University of Calgary, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2022.4116)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Pandemic With Adolescent, Young Adult Eating Disorder Care Volume

JAMA Pediatrics

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 7, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamapediatrics/fullarticle/10.1001/jamapediatrics.2022.4346?guestAccessKey=2534581f-1ad8-4726-8d15-64f6aab67712&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110722

 

About The Study: There was a significant COVID-19 pandemic-related increase in both inpatient and outpatient volume of adolescent and young adult patients with eating disorders (EDs) at geographically diverse academic adolescent medicine programs, particularly in the first year of the pandemic. Given inadequate ED care availability prior to the pandemic, the increased post-pandemic demand will likely outstrip available resources. Results highlight the need to address ED workforce and program capacity issues as well as improve ED prevention strategies.

Authors: Sydney M. Hartman-Munick, M.D., of Boston Children’s Hospital, is the corresponding author.

 

(doi:10.1001/jamapediatrics.2022.4346)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Nicotine Addiction, Intensity of e-Cigarette Use by Adolescents

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, NOVEMBER 7, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40671?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110722

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this survey study of 151,000 students in grades 6 to 12, age at initiation of e-cigarette use decreased and intensity of use and addiction increased between 2014 and 2021. By 2019, more e-cigarette users were using their first tobacco product within 5 minutes of waking than users of cigarettes and all other tobacco products combined. These findings suggest that clinicians need to be ready to address youth addiction to these new highly addictive nicotine products during many clinical encounters, and stronger regulation is needed, including comprehensive bans on the sale of flavored tobacco products.

Authors: Jonathan P. Winickoff, M.D., M.P.H., of Massachusetts General Hospital for Children in Boston, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.40671)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Efficacy of a Hip Brace for Hip Displacement in Children With Cerebral Palsy

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 4, 2022

Media advisory: The full study is linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40383?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110422

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

Visual Abstract

Authors: Ju Seok Ryu, M.D., Ph.D., of the Seoul National University College of Medicine in Seongnam, South Korea, is the corresponding author.

(doi:10.1001/jamanetworkopen.2022.40383)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Medicaid Expansion, Medicare-Financed Hospitalizations Among Adult Patients With Incident Kidney Failure

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3878?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110422

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Coverage, Prior Authorization Policies for Medications for Opioid Use Disorder in Medicaid Managed Care

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.4001?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110422

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Association of Drive Time With Receipt of Guideline-Recommended Screening, Diagnosis, Treatment

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 4, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40290?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110422

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Longer drive time was associated with less frequent receipt of guideline-recommended health care services across multiple components of care. To improve quality of care and health outcomes, health systems and clinicians should adopt strategies to mitigate travel burden, even for urban patients.

Authors: Arianne K. Baldomero, M.D., M.S., of the Minneapolis VA Health Care System, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.40290)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Death and End-of-Life Care in Emergency Departments

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, NOVEMBER 4, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40399?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110422

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers found in this analysis of nationally representative health record data that emergency department (ED) deaths accounted for 11.3% of total deaths from 2010 to 2019, and 33.2% of all decedents nationally visited the ED within one month of their death. These deaths were more common during or after ED visits by patients who were older and those with more comorbidities. These findings suggest emergency medicine practitioners must be able to identify patients for whom end-of-life care is necessary or preferred and have the resources necessary to delivery this care.

Authors: Jonathan Elmer, M.D., M.S., of the University of Pittsburgh, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.40399)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Fracture Risk Among Older Cancer Survivors Compared With Older Adults Without a History of Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5153?guestAccessKey=4b9ee6a0-8c06-4724-a94a-62b411d1afd9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322

Interplay of Immunosuppression, Immunotherapy Among Patients With Cancer and COVID-19

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5357?guestAccessKey=6675d993-046d-41dd-a65b-ff8ef1ddc33e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322

Association of Socioeconomic, Demographic, Health Care Access Disparities With Severe Visual Impairment

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.4566?guestAccessKey=ac2cb709-496a-4cfc-9768-ceca1a708df2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322

The 2022 Monkeypox Outbreak and Monkeypox-Related Ophthalmic Disease

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaophthalmology/fullarticle/10.1001/jamaophthalmol.2022.4567?guestAccessKey=91c01518-6381-4c0a-b731-53dab8926aad&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322

Participation of Patients From Racial, Ethnic Minority Groups in Phase 1 Cancer Drug Development Trials

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 3, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.30884?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110322

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This study compared the proportions of racial and ethnic groups in 221 phase 1 clinical trials of drugs for metastatic cancer from 2000 to 2018 with population-based cancer registry data and found worsening disparities over time in the accrual of patients from racial and ethnic minority groups. These findings may represent widening inequalities in access to trial sites and worsening systemic biases. More efforts are needed to diversify phase 1 cancer drug trials to improve equity in access to new treatments and to ensure that safety and efficacy findings from early drug trials are generalizable across populations.

Authors: C. Jillian Tsai, M.D., Ph.D., of the Princess Margaret Cancer Centre in Toronto, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.30884)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Complexity, Challenges of the Clinical Diagnosis, Management of Long COVID

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 3, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.40332?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110322

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: This analysis of the health records of a random national sample of 200 veterans who had experienced SARS-CoV-2 infection and who had at least one diagnostic code for long COVID highlights the complexity of diagnosing long COVID in clinical settings and the challenges of caring for patients who have or are suspected of having this condition.

Authors: Ann M. O’Hare, M.A., M.D., of the VA Puget Sound Health Care System in Seattle, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.40332)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Visual Abstract: Electroacupuncture vs Sham in Postoperative Ileus Treatment After Laparoscopic Surgery for Colorectal Cancer

JAMA Surgery

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 2, 2022

Media advisory: The full study and commentary are linked to this news release. A visual abstract is below.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.5674?guestAccessKey=98951447-6210-446a-84d3-eae886061982&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110222

 

Visual Abstract

Authors: Cun-Zhi Liu, Ph.D., of the Beijing University of Chinese Medicine in Beijing, and Ying-Chi Yang, Ph.D., of Beijing Friendship Hospital Affiliated to Capital Medical University in Beijing, are the corresponding authors.

 

(doi:10.1001/jamasurg.2022.5674)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Mental Health Care Utilization Among Children, Adolescents With a Firearm Injury

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.5299?guestAccessKey=c70dacae-cf22-4f5a-bb4b-c332029f0f74&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110222

Estimating Savings Opportunities From Therapeutic Substitutions of High-Cost Generic Medications

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 2, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39868?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110222

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: In this analysis of the top 1,000 generics in Colorado’s all-payer claims database in 2019, researchers identified 45 high-cost products that had lower-cost therapeutic alternatives of same clinical value. Overall, high-cost generics were 15.6 times more expensive than their therapeutic alternatives (median values). If the lower-cost alternatives had been used, total spending would have been reduced by 88%. Substitution of high-cost generics may provide a simple pathway to offer the same therapeutic benefit at lower cost to patients and insurers.

Authors: Mariana P. Socal, M.D., Ph.D., of the Johns Hopkins Bloomberg School of Public Health in Baltimore, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.39868)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

COVID-19 Case Investigation, Contact Tracing in New York City

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 2, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39661?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110222

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: Researchers describe the establishment, scaling, and maintenance of Trace, New York City’s COVID-19 contact tracing program and provide data on outcomes during its first 17 months.

Authors: Kathleen Blaney, M.P.H., R.N., of the New York City Department of Health and Mental Hygiene in Queens, New York, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.39661)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39758?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110122

Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 1, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39485?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110122

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The results of this cross-sectional study suggest that between 2015 and 2019 an estimated 1 in 8 total deaths among U.S. adults ages 20 to 64 were attributable to excessive alcohol use, including 1 in 5 deaths among adults ages 20 to 49. The number of premature deaths could be reduced with increased implementation of evidenced-based, population-level alcohol policies, such as increasing alcohol taxes or regulating alcohol outlet density.

Authors: Marissa B. Esser, Ph.D., of the Centers for Disease Control and Prevention in Atlanta, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.39485)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Hormone Therapy With Depression During Menopause

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 1, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39491?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110122

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The findings of this study of women in Denmark followed up from age 45 suggest that systemically administered (oral or transdermal) hormonal therapy before and during menopause is associated with higher risk of depression, especially in the years immediately after initiation, whereas locally administered (intravaginal or intrauterine) hormonal therapy is associated with lower risk of depression for women 54 years or older.

Authors: Merete Osler, M.D., Ph.D., D.M.Sc., of the Bispebjerg and Frederiksberg Hospitals in Frederiksberg, Denmark, is the corresponding author.

  

(doi:10.1001/jamanetworkopen.2022.39491)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Estimated Travel Time, Access to Abortion Facilities Before, After Dobbs v Jackson Women’s Health Decision

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 1, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20424?guestAccessKey=70c1bc40-5cc0-4bcf-a73d-a5b9b26ccf01&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

About The Study: In this analysis, estimated travel time to abortion facilities in the U.S. was significantly greater in the post-Dobbs period after accounting for the closure of abortion facilities in states with total or 6-week abortion bans compared with the pre-Dobbs period, during which all facilities providing abortions in 2021 were considered active.

Authors: Yulin Hswen, Sc.D., of the University of California, San Francisco, is the corresponding author.

 

(doi:10.1001/jama.2022.20424)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Texas’ Abortion Ban With the Number of Facility-Based Abortions in Texas, Surrounding States

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 1, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.20423?guestAccessKey=632f2f19-ea02-46ff-814b-a95d7b371568&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

About The Study: Among a sample of abortion facilities, the 2021 Texas law banning abortion in early pregnancy (SB 8) was significantly associated with a decrease in the documented total of facility-based abortions in Texas and obtained by Texas residents in surrounding states in the first month after implementation compared with the previous month. Over the 6 months following SB 8 implementation, the percentage of out-of-state abortions among Texas residents obtained at 12 or more weeks of gestation significantly increased.

Authors: Kari White, Ph.D., M.P.H., of the University of Texas at Austin, is the corresponding author.

 

(doi:10.1001/jama.2022.20423)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Association of Stroke, Cerebrovascular Pathologies With Scam Susceptibility in Older Adults

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaneurology/fullarticle/10.1001/jamaneurol.2022.3711?guestAccessKey=70307683-4dba-4863-a387-fe3889252cb4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=103122

Health Care Access and Reproductive Rights

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 1, 2022

 

About This Issue: This issue of JAMA includes original research and eight scholarly Viewpoints that provide data and perspective about abortion care and the larger context of evidence-based health care. In addition, there is an editorial, Medical News articles and a Patient Page on medication abortion. Also included in this news release are related articles from the JAMA Network.

 

The full articles are linked to this news release. The links below the titles of the articles will provide readers free access to the full-text article at the embargo time.

 

 

JAMA 

Original Research 

Associations of Unintended Pregnancy With Maternal and Infant Health Outcomes 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19097?guestAccessKey=6d5537a7-b4df-442a-ae21-d59617a7a2ea&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Adverse Maternal and Delivery Outcomes in Children and Very Young (Age ≤13 Years) US Adolescents Compared With Older Adolescents and Adults 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18340?guestAccessKey=224963f0-8409-4925-b85f-87dbc2f6c0d9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Requests for Self-managed Medication Abortion Provided Using Online Telemedicine in 30 US States Before and After the Dobbs v Jackson Women’s Health Organization Decision 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18865?guestAccessKey=0bf9b1b5-f43a-4a80-9cd6-294fac7370cf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Editorial 

Health Care Access and Reproductive Rights 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19172?guestAccessKey=2b6b2fe5-334a-4676-97d3-800929283960&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Viewpoints 

Advancing Birth Equity in a Post-Dobbs US 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19468?guestAccessKey=b74374fb-b2a2-47ff-991e-5a420759aa34&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

The Challenge of Emergency Abortion Care Following the Dobbs Ruling 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.17197?guestAccessKey=962dbb2a-7690-49c7-8eb2-cc9a9d160f2b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Self-managed Abortion in the US 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19057?guestAccessKey=84caf7c0-0ff4-4fc0-bb7a-0dbd81c3d868&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Legal Risks and Ethical Dilemmas for Clinicians in the Aftermath of Dobbs 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18453?guestAccessKey=d3101b78-3d8a-4101-9ebd-3e2a4ab240a7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Implications of the Dobbs Decision for Medical Education – Inadequate Training and Moral Distress 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.19544?guestAccessKey=54d58800-a8e1-4698-915e-498128ffe44a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

The Shift From Criminalization to Legalization of Abortion in Argentina 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18971?guestAccessKey=f2e1285d-1d40-424c-abb1-067a814e0e19&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Confronting the Medical Community’s Complicity in Marginalizing Abortion Care 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18328?guestAccessKey=28459bb2-ad78-4762-8458-b72f0c1fdc3a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Interoperability in a Post-Roe Era – Sustaining Progress While Protecting Reproductive Health Information 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.17204?guestAccessKey=fd35e0ad-beff-4c3a-b6c0-80543a8ba27b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Medical News 

Dobbs Decision Threatens Full Breadth of Ob-Gyn Training 

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.13662?guestAccessKey=00fa5e30-5dab-4578-aab1-9aec6827d1b2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

JAMA Network Open 

Original Research  

Changes in the Clinical Workforce Providing Contraception and Abortion Care in the US, 2019-2021 

http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39657?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=110122 

 

JAMA Surgery 

Viewpoint 

The Dobbs v Jackson Women’s Health Organization Supreme Court Decision – Concerns, Challenges, and Consequences for Health Care 

https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.5714?guestAccessKey=4e0dd68f-7197-4227-b10a-0bd2abafbc4e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

Editorial

The A Word – Our Collective Scarlet Letter

https://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2022.6638?guestAccessKey=b850a26c-ad53-4d19-950b-72b304f51897&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Previously Released  

Medical News 

Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions 

Treating Cancer in Pregnant Patients After Roe v Wade Overturned 

 

JAMA Patient Page 

Medication Abortion

 

Editor’s Note: Please see the articles for additional information, including author contributions and affiliations, conflict of interest and financial disclosures, and funding and support. 

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations

Association Between Price, Measures of Efficacy for Oncology Drugs Approved by FDA

JAMA Internal Medicine

EMBARGOED FOR RELEASE: 11 A.M. (ET), MONDAY, OCTOBER 31, 2022

Media advisory: The full study and editorial are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.4924?guestAccessKey=a0b37add-e1a5-4e8a-9b6b-c2eab0e59eaf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=103122

 

About The Study: This study examined Food and Drug Administration (FDA) anticancer drug approvals in recent years and evaluated if an association exists between their cost and efficacy.

Authors: Vinay Prasad, M.D., M.P.H., of the University of California, San Francisco, is the corresponding author.

 

(doi:10.1001/jamainternmed.2022.4924)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

USPSTF Recommendation Statement on Hormone Therapy for Prevention of Postmenopausal Conditions

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, NOVEMBER 1, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.18625?guestAccessKey=4927b8e8-df65-4c08-a3e1-7c0d5ab6b4ee&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110122

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal persons and against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal persons who have had a hysterectomy. This recommendation applies to asymptomatic, postmenopausal persons who are considering hormone therapy for the primary prevention of chronic medical conditions. The prevalence and incidence of most chronic diseases (such as cardiovascular disease, cancer, osteoporosis, and fracture) increase with age, and U.S. persons who reach menopause are expected on average to live more than another 30 years. However, the excess risk for chronic conditions that can be attributed to menopause alone is uncertain. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and this recommendation is consistent with its 2017 statement on hormone therapy for the primary prevention of chronic conditions in postmenopausal women.

 

(doi:10.1001/jama.2022.18625)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.

State-Issued COVID-19 Vaccine Mandates, Rates of Vaccine Administration

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3810?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102822

Lobbying Expenditures in the Health Care Sector, 2000-2020

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3801?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102822

Analysis of Medicaid Expansion and Access to Prenatal Care Among Immigrant vs US-Born Women

JAMA Network Open

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, OCTOBER 28, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2022.39264?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102822

About JAMA Network Open: JAMA Network Open is the new online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

 

About The Study: The results of this study suggest that exclusions from Medicaid eligibility based on immigration status may be associated with increased health care disparities among some immigrant groups. This finding has relevance to current policy debates regarding Medicaid coverage during and outside of pregnancy.

 Authors: Teresa Janevic, Ph.D., M.P.H., of the Icahn School of Medicine at Mount Sinai in New York, is the corresponding author.

 

(doi:10.1001/jamanetworkopen.2022.39264)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

Trends in Racial, Ethnic Disparities in Barriers to Timely Medical Care

JAMA Health Forum

EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, OCTOBER 28, 2022

Media advisory: The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2022.3856?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=102822

About JAMA Health Forum: JAMA Health Forum has transitioned from an information channel to an international, peer-reviewed, online, open access journal that addresses health policy and strategies affecting medicine, health and health care. The journal publishes original research, evidence-based reports and opinion about national and global health policy; innovative approaches to health care delivery; and health care economics, access, quality, safety, equity and reform. Its distribution will be solely digital and all content will be freely available for anyone to read.

 

About The Study: The findings of this study of survey data including 590,000 adults suggest that barriers to timely medical care in the U.S. increased for all population groups from 1999 to 2018, with associated increases in disparities among race and ethnicity groups. Interventions beyond those currently implemented are needed to improve access to medical care and to eliminate disparities among race and ethnicity groups.

Authors: Harlan M. Krumholz, M.D., S.M., of Yale New Haven Hospital in New Haven, Connecticut, is the corresponding author.

 

(doi:10.1001/jamahealthforum.2022.3856)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.